GILEAD. Gilead Biomedical Research Grants

Features

Whereas the generation of scientific knowledge in the field of the sciences of the
Health, its dissemination, and its application to healthcare practice are key to achieving
To promote progress and improve citizens’ living conditions, GILEAD SCIENCES, S.L.U. promotes the “12th Call for Applications for Gilead Scholarships for Biomedical Research in HIV, Hematology-Oncology, and Medical Oncology.”

Proposals submitted under this call for proposals may only pertain to research projects conducted within the national territory and with an implementation period not exceeding 24 months. This period will begin on the date the agreement for business collaboration on activities of general interest is signed, as referred to in the “Grant Award and Notification” section of this website. Grants awarded under this call for proposals will take the form of a monetary contribution of a variable amount that may not exceed 55,000 euros per project, which will include administrative management expenses.

Projects must fall within one of the following research areas:

• HIV:
  • Research to improve knowledge and the care cascade (Care Cascade) in
    certain subpopulations of people living with HIV:
    • older adults (aging among people living with HIV)
    • women
    • transgender people
    • migrant population
    • sex workers
    • homeless people.
  • Research on innovative care strategies to improve early diagnosis
    and follow-up of people living with HIV
  • Research on Improving Access to and Implementation of PrEP

• Hematology-Oncology: B-cell non-Hodgkin lymphomas (diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma, mantle cell lymphoma, follicular lymphoma)
  • Automation projects and initiatives to implement improvements to existing processes
    for CAR-T therapy treatment.
  • Projects aimed at facilitating the identification of patients who are candidates for CAR-T treatment and
    improving coordination among different levels of care to expedite treatment with
    CAR-T therapy.
  • Strategies aimed at improving comprehensive patient management programs, a multidisciplinary “
    ” approach, referral, and coordination of care for CAR-T therapy treatment.
  • Clinical projects related to the study of prognostic variables and predictive
    factors—including imaging techniques, laboratory tests, and
    innovative applications of new technologies such as artificial intelligence—associated with
    CAR-T cell therapy.
  • Characterization of mechanisms of resistance to CAR-T cell therapy.
  • Studies on the economic burden of the disease and cohort follow-up of patients
    treated with CAR-T therapy in routine clinical practice.
  • Preclinical and translational studies on predictive factors and mechanisms of resistance
    to CAR-T therapy.

• Medical Oncology (Solid Tumors)
  • Clinical or clinical-translational projects involving patients with solid tumors in which
    innovative applications in oncology are developed using new technologies, such as
    artificial intelligence, applied to clinical or molecular data.
  • Clinical or clinical-translational projects on solid tumors related to the study of
    , prognostic variables, and predictive variables.
  • Cohort studies or case-control studies.

Ways to Participate:

Research project proposals may be submitted in one of the following formats
options:

• Single-center study: a project submitted by a single beneficiary applicant
  in accordance with the provisions of the Second Rule of this call for proposals, and conducted at a single
  clinical care center. Such projects may involve subcontracting, in which case the grant recipient must
  ensure that the subcontracting is carried out in accordance
  with applicable laws and regulations.

• Multicenter study: a project submitted by a single beneficiary applicant
  in accordance with the provisions of the Second Rule of this call for proposals and carried out at several
  clinical care centers. The coordinating center must list the participating centers
  in the application.

Requirements:

All proposals submitted must fall into one of the following categories of
research groups:

• Groups led by researchers born in 1985 or later, with a
  track record of scientific output that suggests they have the potential to become
  highly competitive groups, which must submit proposals for
  distinctive and innovative research initiatives that do not involve the breakup of preexisting groups.

• Regular groups (led by researchers born before 1985) must
  meet the general conditions set forth in the various sections, without
  any other specific requirements.

How to apply

Applications to participate in this call for proposals must be submitted online through this website www.BecasGileadInvestigacion.es.

For this Twelfth Call for Proposals, all information must be submitted in English (project proposal and researchers’ CVs); therefore, projects submitted in any language other than English will not be evaluated.

Each principal investigator may submit only one research project proposal. A maximum of two projects may be submitted per therapeutic area and healthcare facility. A “healthcare facility” is defined as the facility to which the project’s principal investigator is affiliated.

At most, only one project may be awarded per therapeutic area and per healthcare facility to which the project’s principal investigator is affiliated. For each application, the category of research group in which the applicant participates must be indicated (a group led by researchers born in 1985 or later, or a group led by researchers born before 1985).

The information required for an application to be evaluated is as follows:

• Research Project Report in accordance with the provided template.
• Abbreviated Curriculum Vitae (CVA-ISCIII), automatically generated by the CVN editor (http://cvn.fecyt.es/editor) or from any institution certified under the FECYT’s CVN standard that offers the CVA-ISCIII service, for the principal investigator and all other collaborators.
• Authorization from the director of the healthcare facility where the “
  ” Project will be carried out, in accordance with the provided form.
• Articles of Incorporation of the applicant organization.
• Power of representation of the entity’s signatory.
• Registration of said entity in the appropriate registry.
• Certificate of Public Benefit Status for Associations.